IVA – inventiva s.a. - american depository shares (US:NASDAQ)
Stock Stats
News
Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference
Inventiva secures €21.4 million and completes the first tranche of the previously announced multi-tranche financing of up to €348 million
Results of the votes of the Combined Shareholders’ General Meeting of December 11, 2024
Inventiva S.A. (NASDAQ: IVA) had its price target lowered by analysts at Stifel Nicolaus from $20.00 to $17.00. They now have a "buy" rating on the stock.
Inventiva reports 2024 Third Quarter Financial Information¹
Form SCHEDULE 13D/A Inventiva S.A. Filed by: BIOTECHNOLOGY VALUE FUND L P
Form 6-K Inventiva S.A. For: Dec 16
Form 6-K Inventiva S.A. For: Dec 12
Form 6-K Inventiva S.A. For: Nov 26
Form 6-K Inventiva S.A. For: Nov 21
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.